Medicine & Life Sciences
Devazepide
76%
Cholecystokinin Receptors
69%
Cholesterol
35%
Gallstones
27%
Crystallization
23%
Gallbladder Emptying
22%
Intestinal Absorption
16%
Bile
14%
Gallbladder
10%
Liver
7%
Chylomicrons
6%
Residual Volume
5%
Gastrointestinal Diseases
5%
Metabolic Diseases
5%
Bile Acids and Salts
5%
Inbred C57BL Mouse
4%
Biological Availability
4%
Meals
4%
Phospholipids
4%
Oral Administration
4%
Therapeutic Uses
3%
Fasting
3%
Fats
3%
Diet
3%
Lipids
3%
Clinical Trials
3%
Animals
2%
Chemical Compounds
Devazepide
100%
Agent Interacting With Transmitter, Hormone or Drug Receptor
53%
Cholesterol
43%
Crystallization
10%
Bile Salt
6%
Bioavailability
4%
Crystal Growth
4%
Phospholipid
4%
Metabolic
3%
Pharmacological Metabolism
3%
Lipid
3%
Volume
2%